Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Human immunodeficiency virus 1 | Integrase | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Plasmodium yoelii | integrase-related | Get druggable targets OG5_139608 | All targets in OG5_139608 |
Trypanosoma congolense | RNA helicase, putative | Get druggable targets OG5_139608 | All targets in OG5_139608 |
Schistosoma mansoni | hypothetical protein | Get druggable targets OG5_139608 | All targets in OG5_139608 |
Trypanosoma brucei | RNA helicase, putative | Get druggable targets OG5_139608 | All targets in OG5_139608 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Toxoplasma gondii | 3-oxo-5-alpha-steroid 4-dehydrogenase | 0.0053 | 0.3812 | 0.5 |
Entamoeba histolytica | steroid 5-alpha reductase, putative | 0.0053 | 0.3812 | 0.5 |
Echinococcus multilocularis | 3 oxo 5 alpha steroid 4 dehydrogenase, C terminal | 0.0053 | 0.3812 | 1 |
Trichomonas vaginalis | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative | 0.0053 | 0.3812 | 0.5 |
Brugia malayi | 3-oxo-5-alpha-steroid 4-dehydrogenase 1 | 0.0053 | 0.3812 | 1 |
Trypanosoma cruzi | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative | 0.0053 | 0.3812 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0053 | 0.3812 | 1 |
Echinococcus multilocularis | synaptic glycoprotein sc2 | 0.0053 | 0.3812 | 1 |
Plasmodium vivax | polyprenol reductase, putative | 0.0053 | 0.3812 | 0.5 |
Trichomonas vaginalis | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative | 0.0053 | 0.3812 | 0.5 |
Trypanosoma cruzi | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative | 0.0053 | 0.3812 | 0.5 |
Schistosoma mansoni | synaptic glycoprotein sc2 related | 0.0053 | 0.3812 | 0.3812 |
Plasmodium vivax | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative | 0.0053 | 0.3812 | 0.5 |
Trichomonas vaginalis | synaptic glycoprotein sc2, putative | 0.0053 | 0.3812 | 0.5 |
Plasmodium falciparum | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative | 0.0053 | 0.3812 | 0.5 |
Trichomonas vaginalis | synaptic glycoprotein sc2, putative | 0.0053 | 0.3812 | 0.5 |
Trichomonas vaginalis | synaptic glycoprotein sc2, putative | 0.0053 | 0.3812 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0053 | 0.3812 | 0.5 |
Mycobacterium ulcerans | hypothetical protein | 0.0053 | 0.3812 | 0.5 |
Toxoplasma gondii | 3-oxo-5-alpha-steroid 4-dehydrogenase | 0.0053 | 0.3812 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0053 | 0.3812 | 1 |
Giardia lamblia | Synaptic glycoprotein SC2 | 0.0053 | 0.3812 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0053 | 0.3812 | 1 |
Trichomonas vaginalis | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative | 0.0053 | 0.3812 | 0.5 |
Leishmania major | 3-oxo-5-alpha-steroid 4-dehydrogenase-like protein | 0.0053 | 0.3812 | 0.5 |
Echinococcus granulosus | synaptic glycoprotein sc2 | 0.0053 | 0.3812 | 1 |
Entamoeba histolytica | trans-2,3-enoyl-CoA reductase, putative | 0.0053 | 0.3812 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0053 | 0.3812 | 0.5 |
Echinococcus granulosus | 3 oxo 5 alpha steroid 4 dehydrogenase C terminal | 0.0053 | 0.3812 | 1 |
Schistosoma mansoni | synaptic glycoprotein sc2 related | 0.0053 | 0.3812 | 0.3812 |
Trypanosoma cruzi | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative | 0.0053 | 0.3812 | 0.5 |
Trichomonas vaginalis | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative | 0.0053 | 0.3812 | 0.5 |
Onchocerca volvulus | 0.0053 | 0.3812 | 1 | |
Entamoeba histolytica | hypothetical protein | 0.0053 | 0.3812 | 0.5 |
Plasmodium falciparum | polyprenol reductase, putative | 0.0053 | 0.3812 | 0.5 |
Brugia malayi | Synaptic glycoprotein SC2 | 0.0053 | 0.3812 | 1 |
Entamoeba histolytica | 3-oxo-5-alpha-steroid 4-dehydrogenase domain-containing protein | 0.0053 | 0.3812 | 0.5 |
Trypanosoma brucei | RNA helicase, putative | 0.0125 | 1 | 1 |
Toxoplasma gondii | 3-oxo-5-alpha-steroid 4-dehydrogenase | 0.0053 | 0.3812 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 5.3 | Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis | ChEMBL. | 21371895 |
IC50 (binding) | = 5 uM | Inhibition of Human immunodeficiency virus 1 integrase strand transfer activity after 30 mins by polyacrylamide gel electrophoresis | ChEMBL. | 21371895 |
IC50 (binding) | = 11 uM | Inhibition of Human immunodeficiency virus 1 integrase-mediated 3'-processing after 30 mins by polyacrylamide gel electrophoresis | ChEMBL. | 21371895 |
IC50 (ADMET) | = 24.4 uM | Cytotoxicity against human PBMC after 5 days by trypan blue assay | ChEMBL. | 21371895 |
IC50 (ADMET) | = 27.5 uM | Cytotoxicity against human CEM cells after 5 days by trypan blue assay | ChEMBL. | 21371895 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.